PEOPLE - Cardima (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Cardima (Fremont, California), a developer of systems for the minimally invasive treatment of atrial fibrillation, has appointed Daniel Cher to the newly-created role of medical director. The company hopes that Dr Cher, who most recently served as managing scientist at consultancy Exponent Failure Analysis, will strengthen Cardima's presence in regulatory and clinical activities worldwide. At Exponent, Dr Cher was responsible for managing scientific consultation projects in the areas of clinical trial design and analysis for several large and small device companies, including obtaining the PMA approval for Essure, the female sterilisation device manufactured by Conceptus.